Pharmaceuticals Export Promotion Council of India

Pharmaceuticals Export Promotion Council of India
Name	Pharmaceuticals Export Promotion Council of India
Formation	2004
Type	Trade promotion organization
Headquarters	New Delhi
Location	India
Leader title	Chairman

Pharmaceuticals Export Promotion Council of India is a trade promotion body established to facilitate and promote the export of pharmaceutical products from India. It operates from New Delhi and engages with regulatory agencies, industry associations, international buyers, and multilateral institutions to expand market access for Indian manufacturers. The council coordinates with export promotion schemes, standard-setting organizations, and financial institutions to enhance competitiveness of Indian pharmaceutical exports.

History

The council was constituted in the early 21st century amid initiatives by the Ministry of Commerce and Industry and the Directorate General of Foreign Trade to consolidate export promotion similar to models used by the Agriculture and Processed Food Products Export Development Authority and the Engineering Export Promotion Council. Its formation responded to trade liberalization trends observed after India's accession to the World Trade Organization and shifting regulatory regimes influenced by the World Health Organization and the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. Early collaborations included dialogues with the Pharmaceuticals and Medical Devices Agency (PMDA) and the European Medicines Agency to address market entry issues. Over time, the council aligned with national frameworks such as the Make in India initiative and export incentive schemes administered by the Ministry of Finance and the Department for Promotion of Industry and Internal Trade.

Organization and Governance

The council's governance mirrors structures seen in bodies like the Federation of Indian Export Organisations and regional export promotion agencies. Its board comprises representatives nominated by the Central Board of Indirect Taxes and Customs, major trade associations such as the Indian Drug Manufacturers' Association and the Organisation of Pharmaceutical Producers of India, as well as ex-officio members from the Ministry of Health and Family Welfare. Administrative functions are overseen by an executive director supported by committees on quality, international trade policy, and market access akin to committees in the Confederation of Indian Industry and the Federation of Indian Chambers of Commerce & Industry. The council engages consultants and auditors from firms similar to PricewaterhouseCoopers, Ernst & Young, and legal advisors experienced with the Drug Controller General of India regulatory framework.

Functions and Services

The council provides export intelligence, market research, and trade facilitation services comparable to those offered by the Tobacco Board and the Spices Board of India. It organizes trade delegations, buyer-seller meets, and participation in international trade fairs such as CPhI Worldwide, Arab Health, and Medic East Africa. It offers guidance on compliance with pharmacopoeias like the United States Pharmacopeia, the British Pharmacopoeia, and the Indian Pharmacopoeia Commission standards, and interfaces with standards bodies including the Bureau of Indian Standards. The council also assists members with export documentation processes linked to the Indian Customs Electronic Gateway (ICEGATE) and connects firms to export credit and insurance schemes managed by entities like the Export Credit Guarantee Corporation of India.

Export Promotion Initiatives and Programs

Initiatives include targeted market development programs for regions covered by the Association of Southeast Asian Nations, the African Union, and the European Union. The council conducts capacity-building programs with training partners modeled on collaborations between United Nations Industrial Development Organization and national export promotion agencies. It runs quality improvement workshops referencing regulatory expectations of agencies such as the US FDA and the Health Products Regulatory Authority (Ireland), and trade policy advocacy aligning with deliberations at forums like the World Trade Organization accession committees and G20 trade working groups. Promotional campaigns have paralleled national efforts seen in Invest India and leveraged bilateral trade dialogues with countries including Russia, Brazil, and South Africa.

Membership and Industry Representation

Membership comprises small and large manufacturers, contract research organizations, and exporters represented similarly to constituents of the Indian Council of Medical Research and the Biotechnology Industry Research Assistance Council. Firms join to access export intelligence, preferential participation in missions, and dispute resolution support analogous to services provided by the Council of Indian Employers. The council liaises with state pharmaceutical clusters such as those in Hyderabad, Ahmedabad, and Bengaluru, and coordinates with trade bodies including the All India Organization of Chemists and Druggists and the Indian Pharmacopoeia Commission for standards alignment.

Impact on India's Pharmaceutical Exports

The council's activities coincided with expansion of exports of generic formulations, active pharmaceutical ingredients, and biosimilars from India to markets like the United States, United Kingdom, Germany, and a widening footprint in Latin America. Its market development programs contributed to increased participation in trade fairs such as CPhI India and facilitated regulatory dialogues that aided exporters in meeting US FDA and European Medicines Agency requirements. The council's export intelligence supported diversification into regulated and semi-regulated markets including members of the Association of Southeast Asian Nations and nations in the Middle East, helping India retain competitiveness vis-à-vis producers in China and South Korea.

Challenges and Criticism

Critiques reflect concerns raised by stakeholders in forums like the Parliament of India and industry roundtables convened by the Confederation of Indian Industry about insufficient support for small-scale exporters, gaps in cold-chain export infrastructure exemplified in logistics hubs compared to Dubai and Rotterdam, and the need for stronger engagement on intellectual property matters involving the World Intellectual Property Organization. Observers cite challenges in navigating divergent regulatory regimes from the US FDA and the European Medicines Agency, and call for enhanced coordination with research institutions such as the Indian Council of Medical Research and international partners like the Bill & Melinda Gates Foundation to address quality, compliance, and market access bottlenecks.

Category:Pharmaceutical industry in India Category:Export promotion agencies of India